Edition:
United Kingdom

Rite Aid Corp (RAD.N)

RAD.N on New York Stock Exchange

1.07USD
20 Nov 2018
Change (% chg)

$-0.11 (-9.32%)
Prev Close
$1.18
Open
$1.16
Day's High
$1.16
Day's Low
$1.07
Volume
2,171,320
Avg. Vol
1,992,167
52-wk High
$2.55
52-wk Low
$0.98

Latest Key Developments (Source: Significant Developments)

Walgreens Boots Alliance Reports Fiscal Year 2018 Results
Thursday, 11 Oct 2018 

Oct 11 (Reuters) - Walgreens Boots Alliance Inc ::WALGREENS BOOTS ALLIANCE REPORTS FISCAL YEAR 2018 RESULTS.Q4 ADJUSTED EARNINGS PER SHARE $1.48.Q4 EARNINGS PER SHARE $1.55.Q4 EARNINGS PER SHARE VIEW $1.45 -- THOMSON REUTERS I/B/E/S.INTRODUCED GUIDANCE OF 7 PERCENT TO 12 PERCENT GROWTH IN FISCAL 2019 ADJUSTED EPS AT CONSTANT CURRENCY RATES.AT CURRENT EXCHANGE RATES THIS RESULTS IN AN ESTIMATED RANGE OF $6.40 TO $6.70 FOR FISCAL 2019 ADJUSTED EPS.INTEGRATION OF ACQUIRED RITE AID STORES IS ON TRACK.RETAIL PHARMACY INTERNATIONAL HAD Q4 SALES OF $2.9 BILLION, A DECREASE OF 1.9 PERCENT.RETAIL PHARMACY USA HAD Q4 SALES OF $25.5 BILLION, AN INCREASE OF 14.4 PERCENT OVER YEAR-AGO QUARTER.Q4 RETAIL PHARMACY INTERNATIONAL COMPARABLE PHARMACY SALES DECREASED 3.4 PERCENT ON A CONSTANT CURRENCY BASIS.QTRLY RETAIL PHARMACY USA SALES IN COMPARABLE STORES INCREASED 0.3 PERCENT COMPARED WITH SAME QUARTER A YEAR AGO.FISCAL 2019 GUIDANCE ALSO ASSUMES CONTINUED EXECUTION OF PREVIOUSLY ANNOUNCED $10 BILLION SHARE REPURCHASE PROGRAM.QTRLY SALES INCREASED 10.9 PERCENT TO $33.4 BILLION.Q4 REVENUE VIEW $33.78 BILLION -- THOMSON REUTERS I/B/E/S.FY2019 EARNINGS PER SHARE VIEW $6.45 -- THOMSON REUTERS I/B/E/S.  Full Article

International Brotherhood Of Teamsters Urges Rite Aid Corp Shareholders To Vote Against Say-On-Pay Proposal On October 30
Friday, 5 Oct 2018 

Oct 5 (Reuters) - Rite Aid Corp ::INTERNATIONAL BROTHERHOOD OF TEAMSTERS URGES RITE AID CORP SHAREHOLDERS TO VOTE AGAINST SAY-ON-PAY PROPOSAL ON OCTOBER 30 - SEC FILING.  Full Article

Rite Aid Announces Ratification Of 3-year Agreement With UFCW In Southern California
Tuesday, 2 Oct 2018 

Oct 2 (Reuters) - Rite Aid Corp ::RITE AID ANNOUNCES RATIFICATION OF THREE YEAR AGREEMENT WITH UFCW IN SOUTHERN CALIFORNIA.RITE AID CORP - ANNOUNCE RATIFICATION OF A 3-YEAR AGREEMENT WITH UFCW COVERING OVER 5,900 RITE AID ASSOCIATES.  Full Article

Rite Aid Corp - CEO John Standley's 2018 Pay Was $9.3 Mln Vs $8.1 Mln In 2017
Thursday, 27 Sep 2018 

Sept 27 (Reuters) - Rite Aid Corp ::RITE AID CORP - CEO JOHN T. STANDLEY'S 2018 TOTAL COMPENSATION WAS $9.3 MILLION VERSUS $8.1 MILLION IN 2017 - SEC FILING.RITE AID CORP SAYS BOARD HAS DECIDED TO SEPARATE THE POSITIONS OF CHAIRMAN AND CHIEF EXECUTIVE OFFICER - SEC FILING.RITE AID CORP SAYS BRUCE G. BODAKEN WILL HOLD THE POSITION OF CHAIRMAN EFFECTIVE AT THE 2018 ANNUAL MEETING OF STOCKHOLDERS.RITE AID - THREE OF CURRENT EIGHT INDEPENDENT DIRECTORS WILL NOT BE STANDING FOR RE-ELECTION AND WE ARE NOMINATING THREE NEW INDEPENDENT DIRECTORS.RITE AID CORP - BOARD FIRMLY BELIEVES THAT JOHN STANDLEY IS BEST SITUATED TO SERVE AS RITE AID'S CHIEF EXECUTIVE OFFICER.  Full Article

Rite Aid Q2 Loss Per Share $0.33 From Continuing Operations
Thursday, 27 Sep 2018 

Sept 27 (Reuters) - Rite Aid Corp ::RITE AID REPORTS FISCAL 2019 SECOND QUARTER RESULTS.Q2 ADJUSTED LOSS PER SHARE $0.01 FROM CONTINUING OPERATIONS.Q2 LOSS PER SHARE $0.33 FROM CONTINUING OPERATIONS.Q2 REVENUE $5.4 BILLION VERSUS I/B/E/S VIEW $5.36 BILLION.SEES FY 2019 REVENUE $21.7 BILLION TO $22.1 BILLION.Q2 EARNINGS PER SHARE VIEW $-0.01 -- THOMSON REUTERS I/B/E/S.CONFIRMING ITS FISCAL 2019 OUTLOOK FOR REVENUES, SAME STORE SALES, ADJUSTED EBITDA AND CAPITAL EXPENDITURES.2019 NET LOSS EXPECTED TO BE BETWEEN $440 MILLION AND $485 MILLION DUE TO IMPAIRMENT CHARGES INCURRED DURING THE QUARTER.  Full Article

Albertsons Companies And Rite Aid Mutually Agree To Terminate Merger Agreement
Thursday, 9 Aug 2018 

Albertsons Companies Inc ::ALBERTSONS COMPANIES AND RITE AID MUTUALLY AGREE TO TERMINATE MERGER AGREEMENT.ALBERTSONS - DISAGREE WITH CERTAIN RITE AID STOCKHOLDERS, THIRD-PARTY ADVISORY FIRMS THAT DID NOT BELIEVE CO WAS OFFERING SUFFICIENT MERGER CONSIDERATION.ALBERTSONS COMPANIES- CO WAS UNWILLING TO CHANGE TERMS OF MERGER.ALBERTSONS COMPANIES - REAFFIRMED ITS FISCAL 2018 OUTLOOK, WHICH INCLUDES AN EXPECTATION FOR ADJUSTED EBITDA OF $2.7 BILLION.  Full Article

Rite Aid, Albertsons Mutually Agree To Terminate Merger Agreement
Thursday, 9 Aug 2018 

Aug 8 (Reuters) - Rite Aid Corp ::RITE AID AND ALBERTSONS COMPANIES MUTUALLY AGREE TO TERMINATE MERGER AGREEMENT.EVALUATING GOVERNANCE CHANGES IN CONSULTATION WITH STOCKHOLDERS.SPECIAL MEETING OF RITE AID'S STOCKHOLDERS, WHICH WAS TO BE HELD ON AUGUST 9, 2018, WILL NOT TAKE PLACE.RITE AID WILL CONTINUE TO ENGAGE WITH STOCKHOLDERS TO ENSURE ALIGNMENT BETWEEN COMPANY AND ITS INVESTORS.RITE AID -UNDER TERMS OF MERGER AGREEMENT, NEITHER COS WILL BE RESPONSIBLE FOR PAYMENTS TO OTHER PARTY AS RESULT OF TERMINATION OF MERGER AGREEMENT.HEARD VIEWS EXPRESSED BY STOCKHOLDERS AND CO COMMITTED TO MOVING FORWARD AND EXECUTING STRATEGIC PLAN AS STANDALONE COMPANY.  Full Article

Rite Aid Sees FY 2019 Adjusted Loss Per Share $0.00 To $0.04
Monday, 6 Aug 2018 

Aug 6 (Reuters) - Rite Aid Corp ::RITE AID UPDATES FISCAL 2019 OUTLOOK.SEES FY 2019 ADJUSTED LOSS PER SHARE $0.00 TO $0.04.NET LOSS IS NOW EXPECTED TO BE IN A RANGE BETWEEN $125 MILLION AND $170 MILLION FOR FISCAL 2019.FISCAL 2019 OUTLOOK DOES NOT REFLECT IMPACT OF PROPOSED MERGER WITH ALBERTSONS COMPANIES, INC..GENERIC DRUG PURCHASING EFFICIENCIES WILL NOT MEET COMPANY'S EXPECTATIONS FOR YEAR.ADJUSTED EBITDA IS NOW EXPECTED TO BE IN A RANGE BETWEEN $540 MILLION AND $590 MILLION FOR FISCAL 2019.RITE AID - NOW EXPECTS GENERIC DRUG PURCHASING EFFICIENCIES TO BE ABOUT $80 MILLION LESS THAN WHEN CO ESTABLISHED FISCAL 2019 OUTLOOK.COMPANY'S 2019 OUTLOOK FOR SALES AND SAME STORE SALES REMAINS UNCHANGED.EXPECTATION FOR 2019 CAPITAL EXPENDITURES ALSO REMAINS UNCHANGED..FY2019 EARNINGS PER SHARE VIEW $0.03, REVENUE VIEW $21.74 BILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Walgreens Boots Q3 GAAP Earnings Per Share $1.35
Thursday, 28 Jun 2018 

June 28 (Reuters) - Walgreens Boots Alliance Inc ::WALGREENS BOOTS ALLIANCE REPORTS FISCAL 2018 THIRD QUARTER RESULTS.Q3 ADJUSTED EARNINGS PER SHARE $1.53.Q3 GAAP EARNINGS PER SHARE $1.35.Q3 EARNINGS PER SHARE VIEW $1.48 -- THOMSON REUTERS I/B/E/S.QTRLY SALES INCREASED 14.0 PERCENT TO $34.3 BILLION.SEES 2018 ADJUSTED DILUTED NET EARNINGS PER SHARE OF $5.90 TO $6.05.RETAIL PHARMACY USA HAD Q3 SALES OF $25.9 BILLION, AN INCREASE OF 15.0 PERCENT OVER YEAR-AGO QUARTER.RETAIL PHARMACY INTERNATIONAL HAD Q3 SALES OF $3.0 BILLION, AN INCREASE OF 6.6 PERCENT FROM YEAR-AGO QUARTER.RETAIL PHARMACY USA SALES IN COMPARABLE STORES IN QUARTER DECREASED 1.2 PERCENT COMPARED WITH SAME QUARTER A YEAR AGO.DOES NOT EXPECT RITE AID TO SIGNIFICANTLY IMPACT FISCAL 2018 ADJUSTED DILUTED NET EARNINGS PER SHARE.FY2018 EARNINGS PER SHARE VIEW $5.95 -- THOMSON REUTERS I/B/E/S.WALGREENS BOOTS ALLIANCE - ON CONSTANT CURRENCY BASIS,COMPARABLE STORE SALES DECREASED 1.4 PERCENT VERSUS YEAR-AGO QUARTER FOR RETAIL PHARMACY INTERNATIONAL.Q3 REVENUE VIEW $34.05 BILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Rite Aid Reports Q1 EPS $0.20
Wednesday, 27 Jun 2018 

June 27 (Reuters) - Rite Aid Corp ::RITE AID REPORTS FISCAL 2019 FIRST QUARTER RESULTS.Q1 ADJUSTED LOSS PER SHARE $0.01 FROM CONTINUING OPERATIONS.Q1 LOSS PER SHARE $0.04 FROM CONTINUING OPERATIONS.Q1 EARNINGS PER SHARE $0.20.SEES FY 2019 SALES $21.7 BILLION TO $22.1 BILLION.Q1 REVENUE $5.4 BILLION VERSUS I/B/E/S VIEW $5.32 BILLION.Q1 EARNINGS PER SHARE VIEW $-0.01 -- THOMSON REUTERS I/B/E/S.RITE AID CONFIRMS FISCAL 2019 OUTLOOK.FY2019 EARNINGS PER SHARE VIEW $0.03, REVENUE VIEW $21.65 BILLION -- THOMSON REUTERS I/B/E/S.MERGER WITH ALBERTSONS IS EXPECTED TO CLOSE IN H2 OF CALENDAR YEAR 2018.RITE AID - NET INCOME FOR Q1 INCLUDED AN AFTER-TAX GAIN OF ABOUT $268.6 MILLION RELATING TO SALE OF 281 STORES TO WALGREENS BOOTS ALLIANCE.  Full Article

Photo

Walgreens revenue hit by weakness in personal care products, OTC drugs

Walgreens Boots Alliance Inc came up short of analysts' estimates for quarterly revenue on Thursday, as sales of personal care products and over-the-counter drugs fell both in its home market and at its UK-based Boots chain.